SCGB2A2 and breast carcinoma: Mammaglobin-A (MAM-A), a secretoglobin protein consisting of 93 amino acids, offers promising potential as a target for breast cancer vaccine therapy because of its high expression in breast cancers and minimal presence in healthy tissues [87].